BTK-IN-45 (Compound 6b) is a potent, reversible, and selective BTK inhibitor with an IC50 of 1.14 µM. BTK-IN-45 also exhibits modest inhibition for LCK. BTK-IN-45 can be used in the research of cancers, including leukemia[1].
Molekulargewicht:
333.34
Formel:
C19H15N3O3
Target-Kategorie:
Btk,Src
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
